C83.71 Burkitt lymphoma, lymph nodes of head, face, and neck

Name of the Condition

• Burkitt lymphoma, lymph nodes of head, face, and neck
• Medical term: Burkitt's lymphoma

Summary

Burkitt lymphoma is a highly aggressive form of non-Hodgkin lymphoma that primarily affects B-cells in the lymphatic system. This specific subtype involves the lymph nodes located in the head, face, and neck regions. It is characterized by rapid tumor growth and is often associated with specific genetic and viral factors. Early diagnosis and treatment are critical due to its fast progression.

Causes

The exact causes of Burkitt lymphoma are not fully understood, but it is strongly linked to infection with the Epstein-Barr virus (EBV). Genetic mutations, particularly chromosomal translocations involving the MYC gene, are also key contributors to its development.

Risk Factors

• Epstein-Barr virus (EBV) infection
• Human immunodeficiency virus (HIV) infection
• Weakened immune system from other conditions or treatments
• Young age, especially in children and young adults
• Geographic regions with high EBV prevalence, such as equatorial Africa

Symptoms

• Rapidly growing, painless lymph node swelling in the head, face, or neck
• Fever
• Night sweats
• Unexplained weight loss
• Fatigue
• Possible facial swelling or discomfort if lymph nodes are enlarged

Diagnosis

Diagnosis involves a physical examination to assess lymph node or organ swelling, followed by imaging tests (e.g., CT or MRI) to identify tumor locations. A biopsy of affected tissue is performed to confirm the presence of cancerous cells and determine the specific subtype. Blood tests may also be conducted to evaluate overall health and detect viral infections.

Treatment Options

Treatment typically includes intensive chemotherapy regimens, often combined with immunotherapy or targeted therapy. Radiation therapy may be used in specific cases to address localized tumors. Treatment plans are tailored to the patient's age, overall health, and disease stage.

Prognosis and Follow-Up

With prompt and appropriate treatment, the prognosis for Burkitt lymphoma can be favorable, especially in younger patients. Regular follow-up appointments are essential to monitor for recurrence and manage potential side effects of treatment. Long-term survival rates are higher when the disease is diagnosed early.

Complications

• Tumor lysis syndrome due to rapid cell breakdown during treatment
• Infections from a weakened immune system
• Neurological issues if the lymphoma affects the central nervous system
• Organ damage from tumor growth or treatment side effects

Lifestyle & Prevention

• Maintain a healthy immune system through balanced nutrition and regular medical care
• Avoid known risk factors, such as unprotected exposure to EBV in high-prevalence areas
• Follow recommended vaccination schedules to reduce infection risks
• Seek prompt medical attention for persistent or unusual symptoms

When to Seek Professional Help

Consult a healthcare provider if you experience persistent, painless lymph node swelling in the head, face, or neck, especially if accompanied by fever, night sweats, or unexplained weight loss. Early evaluation is crucial for effective management.

Tips for Medical Coders

When coding for Burkitt lymphoma involving the lymph nodes of the head, face, and neck, ensure the specific anatomical site is clearly documented. Verify that the diagnosis aligns with the clinical findings and that any relevant staging or treatment details are included in the record. Accurate coding requires precise documentation of the affected lymph node regions to support the assigned code.